Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Heritability heightens brain metabolite differences in schizophrenia.

H Fukuzako1

  • 1Department of Neuropsychiatry, Faculty of Medicine, Kagoshima University, Japan. fukuzako@med4.kufm.kagoshima-u.ac.jp

The Journal of Neuropsychiatry and Clinical Neurosciences
|March 4, 2000
PubMed
Summary

Medicated schizophrenic patients exhibit reduced N-acetylaspartate/creatine-phosphocreatine ratios in the medial temporal lobe. This neurochemical difference, detectable via magnetic resonance spectroscopy, was more pronounced in those with a family history of psychosis.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Neurochemical investigation of the schizophrenic brain by in vivo phosphorus magnetic resonance spectroscopy.

The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry·2003
Same author

Aberrant brain activation following motor skill learning in schizophrenic patients as shown by functional magnetic resonance imaging.

Psychological medicine·2001
Same author

Comparisons of event-related potentials after repetitive transcranial magnetic stimulation.

Journal of neurology·2001
Same author

c-Fos expression in rat brain after repetitive transcranial magnetic stimulation.

Neuroreport·2001
Same author

Effects of high frequency repetitive transcranial magnetic stimulation on P(300) event-related potentials.

Clinical neurophysiology : official journal of the International Federation of Clinical Neurophysiology·2001
Same author

Subtype-associated metabolite differences in the temporal lobe in schizophrenia detected by proton magnetic resonance spectroscopy.

Psychiatry research·2000

Area of Science:

  • Neuroscience
  • Psychiatry
  • Medical Imaging

Background:

  • Schizophrenia is a complex psychiatric disorder with suspected neurobiological underpinnings.
  • Alterations in brain metabolism and neurochemistry are increasingly investigated as potential biomarkers.
  • The medial temporal lobe plays a crucial role in memory and emotion, areas often affected in schizophrenia.

Purpose of the Study:

  • To investigate neurochemical differences in the medial temporal lobe of medicated schizophrenic patients compared to healthy controls.
  • To explore the relationship between these neurochemical differences and a family history of psychotic disorders.

Main Methods:

  • Single-voxel proton magnetic resonance spectroscopy (MRS) was utilized.
  • Spectra were acquired from a standardized voxel in the left medial temporal lobe.

Related Experiment Videos

  • A 2.0-tesla whole-body magnetic resonance imaging (MRI) system was employed for data acquisition.

    • Main Results:

    • Schizophrenic patients demonstrated a significantly lower N-acetylaspartate/creatine-phosphocreatine (NAA/Cr) ratio compared to healthy subjects.
    • This reduction in the NAA/Cr ratio was more pronounced in schizophrenic patients with a documented family history of psychotic disorders.
    • The findings suggest metabolic alterations within the medial temporal lobe in schizophrenia.

    Conclusions:

    • Proton magnetic resonance spectroscopy can detect specific neurochemical alterations in the medial temporal lobe of medicated schizophrenic patients.
    • The observed NAA/Cr ratio reduction may serve as a potential imaging biomarker for schizophrenia.
    • Family history of psychosis is associated with more significant metabolic changes in this brain region, suggesting a potential genetic influence on neurochemistry.